Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aleglitazar versus Actos on renal function in adults with type 2 diabetes and moderate renal impairment
2009-012270-12Phase 2Completed
- Sponsor
- Roche
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of aleglitazar in type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD) (2 arms), sponsored by Roche. Started Feb 2010; status: completed.
02
Drugs
aleglitazar
03
Conditions
type 2 diabetes mellitus (T2DM)chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2009-012270-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012270-12.